期刊文献+

他汀类药物的研究进展与临床应用评价 被引量:62

Research Progress on Statins and Evaluation on Its Clinical Application
下载PDF
导出
摘要 目的:评价他汀类药物的研究进展,以供临床医师合理用药参考。方法:查阅近年来国内外的相关文献资料,进行归纳和分析。结果与结论:他汀类药物不仅能降低血清胆固醇水平,还通过改善血管内皮功能、抗炎及抗氧化作用、抗血小板聚集和抑制血栓形成、稳定粥样硬化斑块、抑制平滑肌细胞增殖及迁移等其他多效性,在冠状动脉粥样硬化性心脏病、缺血性脑卒中、糖尿病血管病、心律失常、阿尔茨海默病、高血压等心血管疾病中发挥其作用。国内冠心病患者目前他汀类药物的使用状况存在明显不足,说明这方面的循证医学证据还亟待转化为科学规范的临床实践。 OBJECTIVE:To evaluate the research progress on statins in order to provide references for clinicians about rational drug use.METHODS:By reviewing the pertinent literature both at home and abroad,a systematic meta-analysis was performed on the research progress on statins.RESULTS & CONCLUSION:Statins can not only lower cholesterol levels,but also play a role in the treatment of coronary atherosclerotic heart disease,cerebral ischemic stroke,diabetic angiopathy,arrhythmia,alzheimer disease and hypertension etc through ameliorating the endothelial function of blood vessels,inhibiting platelet aggregation and formation of thrombus,stabilizing atherosclerotic plaque,inhibiting proliferation and migration of smooth muscle cells as well as its anti-inflammatory and antioxidative action.In China,statins were poorly used in patients coronary artery disease,indicating the necessity to transform the evidence in evidenced-based medicine in this filed to scientific and standard clinical practice
作者 杜海燕 林阳
出处 《中国医院用药评价与分析》 2011年第6期488-493,共6页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 他汀类药物 研究进展 临床应用 不良反应 Statins Research progress Clinical application Adverse drug reaction
  • 相关文献

参考文献23

  • 1Sawada N, Itoh H, Nakao K. Novel actions of HMG-CoA reductase inhibitors (statins) vascular and cerebral protection through inhibition of small GTPase Rho [ J ]. Nippon Rinsho ,2001 ,59(12) :2470.
  • 2Amin KA, Abd EI-T wab TM. Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats:role of atorvastatine and cinnamon [ J]. Int J Clin Exp Meal,2009,2(3) :254.
  • 3The Long term Intervention with Pravastatin in lsehemic Disease (LIPID)Study Group. Prevention of cardiovasculsr events and death with pravastatin in patients with coronary head disease and abroad range of initial cholesterol levels [J]. N Engl J Med,1998,339(19 ) :1349.
  • 4Laufs U, Gertz K, Huang P, et al. Atorvastatin upregulates type Ⅲ nitric oxide synthase in thrombocytes, decreases platelet activation,and protects from cerebral ischemia in normocholesterolemicmice [ J ]. Stroke,2000,31 ( 10 ) :2442.
  • 5胡大一 王振纲.防治冠心病和高血压的药物他汀类.中国全科医学杂志,2000,3(2):141-141.
  • 6郭佳,田金徽,杨克虎,任尧尧,姜雷,石正洪.他汀类药物预防卒中再发的系统评价[J].中国循证医学杂志,2009,9(5):565-569. 被引量:11
  • 7Rodriguez-Vita J, S~nchez-Gal6n E, Santamaria B, et al. Essential role of TGF-beta/Smad pathway on statin dependentvascular smoothmuscle cell regulation [ J]. PLoS 0ne,2008,3 ( 12 ) : e3959.
  • 8王兴全.解读他汀类药物防治IS/TIA的专家共识[J].中国实用医药,2010,5(12):250-252. 被引量:7
  • 9Wierzbicki AS, Viljoen A. Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice [ J ]. Drug Saf, 2010,33 ( 2 ) : 115.
  • 10Nieholls SJ, Brandrup-Wognsen G, Palmer M,et al. Meta- analysis of comparative efficacy of increasinE dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids ( from VOYAGER ) [J].Am J Cardiol,2010,105(1) :69.

二级参考文献133

共引文献121

同被引文献586

引证文献62

二级引证文献420

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部